Specifically, CELNs treatment significantly upregulated GABAA R subunits (including α3 and β2) and GABA synthases (including GAD1) in colonic tissues (Figure 3), suggesting that GABA and its receptor system play pivotal roles in CELNs-induced constipation relief. The gene discussed is GAD1; the disease is constipation disorder.